Brain Tumor
Conditions
Keywords
Functional Magnetic Resonance Imaging (fMRI), 18-331
Brief summary
The purpose of this study is to test the accuracy of using an imaging technique called breath-holding functional magnetic resonance imaging (BH fMRI) in addition to the standard imaging test described above. This study will allow the researchers to find out whether using BH fMRI in combination with the standard approach is the same as, better, or worse than the standard approach used alone.
Interventions
DEVICEfMRI Paradigms
T2\*-weighted images will be acquired with a single-shot gradient echo echo-planar imaging (EPI) sequence in the axial orientation (TR=2500ms, TE=30ms, FA=80°, slice thickness=4 mm, FOV= 240mm2, matrix=64×64) covering the whole brain.
Sponsors
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
Health Volunteers * Volunteers between the ages of 18 and 80 years * Volunteers must be able to perform the language paradigms on cue while inside the scanner Patients * Patients between the ages of 18 and 80 years * Patients must be able to perform the language paradigms on cue while inside the scanner * Women of child bearing potential must have a negative pregnancy test prior to the study intervention (Serum or Urine) * Patients diagnosed with primary glial neoplasm, meningioma and metastasis (from prior histology) or must be suspected to have primary glial neoplasm, meningioma and metastasis on imaging (to be confirmed by post-operative histology). * Patient"s location of the tumor must involve the expected location of Broca"s area (left pars opercularis and/or pars triangularis), or the expected location of the primary motor area (the pre-central gyrus). This determination will be made on the basis of a pre-operative MRI by a fellowship-trained Neuroradiologist
Exclusion criteria
Healthy Volunteers * Volunteers who are unable to comply or complete MRI exams as per the site"s standards. (e.g.: claustrophobia, high levels of anxiety, pacemaker etc.) o MSK site only - see Appendix 2 * Volunteers who are unable to perform the language paradigms on cue while inside the scanner (due to weakness, deafness, inability to understand or follow instructions etc.) * Volunteers with a history of neurological disorders, psychiatric disorders or cancer Female volunteers who are pregnant or nursing. * Volunteers who have MRI safe pacemakers. * Volunteers from the vulnerable population, as defined by 45 CFR 46 * Volunteers who are unable to perform the breath hold task during practice sessions Patients * Patients who are unable to comply or complete MRI exams as per the site"s standards. (e.g.: claustrophobia, high levels of anxiety, pacemaker etc.) °MSK site only - see Appendix 2 * Patients who have MRI safe pacemakers. * Patient who are unable to perform the language paradigms on cue while inside the scanner (due to weakness, deafness, inability to understand or follow instructions etc.) * Female patients who are pregnant or nursing. * Patients from the vulnerable population, as defined by 45 CFR 46 * Patients who are unable to perform the breath hold task during practice sessions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients that have false negative results | 2 years | The primary objective is to examine if the false negative results of BOLD fMRI adjacent to brain tumors can be compensated for by measurements of BH-MRI and subsequent calibration of the BOLD response. We will have two sets of data: 1) the data obtained using routine techniques to analyze the BOLD fMRI data; and 2) the data obtained where the BOLD fMRI data was analyzed incorporating BH data. Every data point obtained in 1) will have a corresponding data point using 2), the BH MRI data, to adjust the BOLD fMRI analysis. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORAndrei Holodny, MD
Memorial Sloan Kettering Cancer Center
Outcome results
None listed